Viewing Study NCT03665805


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-15 @ 2:46 AM
Study NCT ID: NCT03665805
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2018-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Postoperative Residual Curarization in 2018
Sponsor: Onze Lieve Vrouw Hospital
Organization:

Study Overview

Official Title: Neuromuscular Monitoring, Reversal of Block and Postoperative Residual Curarization: the Situation in 2018
Status: COMPLETED
Status Verified Date: 2018-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this study is to evaluate the incidence of postoperative residual curarization, as defined by a train-of-four \<90%, upon postanaesthesia care unit arrival. Anesthetists tend to use train-of-four monitoring in the operating theatre to interpret muscle tone. Train-of-four monitoring is a widely used term for the peripheral nerve stimulation used in neuromuscular blockade monitoring. Hypothesizing a change in our practice since 2006-2012 (Cammu G, Anesth Analg 2006; 102: 426-9 and Cammu G, Anaesth Intensive Care 2012; 40: 999-1006), residual neuromuscular block as well as the use of intraoperative neuromuscular transmission monitoring and reversal of neuromuscular blocking agents will again be prospectively evaluated in 2018. The present study aims to compare these three periods (2006-2012-2018) in terms of management of neuromuscular block in the operating room and to look for a relationship with the incidence of postoperative residual curarization.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: